---
title: Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List
nct_id: NCT02710799
overall_status: COMPLETED
phase: NA
sponsor: Hospital de Clinicas de Porto Alegre
study_type: INTERVENTIONAL
primary_condition: Diabetes Mellitus
countries: Brazil
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02710799.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02710799"
ct_last_update_post_date: 2016-08-10
last_seen_at: "2026-05-12T07:24:45.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List

**Official Title:** Evaluation of the Effectivity of Teleconsultations for Improving the Referrals From Primary Care to Specialized Care of Patients With Chronic Endocrinological Conditions

**NCT ID:** [NCT02710799](https://clinicaltrials.gov/study/NCT02710799)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 3470
- **Lead Sponsor:** Hospital de Clinicas de Porto Alegre
- **Collaborators:** Secretaria Estadual da Saúde do Estado do Rio Grande do Sul, Programa de Pesquisa e Pós-Graduação em Epidemiologia da UFRGS, TelessaúdeRS / UFRGS
- **Conditions:** Diabetes Mellitus, Hypothyroidism, Hyperthyroidism, Goiter, Thyroid Nodule, Obesity
- **Start Date:** 2015-06
- **Completion Date:** 2016-06
- **CT.gov Last Update:** 2016-08-10

## Brief Summary

The aim of this study is evaluate the effects of telephone teleconsultations to primary care physicians (compared to the state's referral protocol) in the referrals waiting list for endocrinological appointments.

## Detailed Description

Rio Grande do Sul state's referral list for endocrinology evaluation in specialized care is highly overloaded. There is currently a referral protocol to select patients how should be referred. It will be evaluated if a intervention of telephone-based teleconsultations provided by the TelessaúdeRS to the primary care physicians can provide additional benefits. TelessaúdeRS is a telehealth program from the University of Rio Grande do Sul. This will be evaluated in a cluster randomized clinical trial.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Patients from counties with at least 5 endocrinology referrals waiting appointment.
* Patients referred from primary care physicians
* Patients referred because one of the protocol conditions (Diabetes Mellitus, Hypothyroidism, Hyperthyroidism, Goiter, Thyroid nodule, Obesity).

Exclusion Criteria:

* Patients from counties with more than one hundred endocrinology referrals waiting appointment.
```

## Arms

- **Control** (ACTIVE_COMPARATOR) — Referrals will be evaluated through the state's protocols
- **Intervention** (EXPERIMENTAL) — Referrals will be evaluated through the state's protocols associated with telephone-based teleconsultations.

## Interventions

- **Teleconsultation** (OTHER) — The teleconsultations will be performed by medical doctors, mostly family physicians, but also internists and endocrinologists. The teleconsultations will follow a structured format to discuss some topics on the disease and access the relevant information (based on the state's protocols). The doubts from the primary care physician will be addressed.
- **Protocol** (OTHER) — The informations provided in the referral list will be evaluated through the state's referrals protocols.

## Primary Outcomes

- **Number of consultations authorized** _(time frame: 1 year)_ — Number of consultations authorized after the evaluation by the control and intervention strategies.

## Secondary Outcomes

- **Number of new referrals for endocrinology** _(time frame: 1 year)_
- **Adherence to the state's protocols** _(time frame: 1 year)_
- **Usage of TelessaúdeRS teleconsultations** _(time frame: 1 year)_

## Locations (1)

- Secretaria Estadual da Saúde, Porto Alegre, Rio Grande do Sul, Brazil

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.secretaria estadual da saúde|porto alegre|rio grande do sul|brazil` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02710799.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02710799*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*